ARCHIVES

Alan Davis to Retire From ACS; Five Execs Keep Top Positions

This article is from The Cancer Letter archive.

Vol. 19 No. 35 | September 10, 1993

Download PDF Visit The Full Archive

Related Articles

How Much Is Life Worth? The $440 Billion Question

July 31, 2009

Rosenberg Starts New Study With TIL; LAK-IL-2 Costs Clarified

November 28, 1986

In Brief: Yarbro To Leave As NCI Centers Chief to Head Missouri Cancer Program; Replaced By Cantril

May 30, 1975

NI Consortium for cancer Genetics; Working Group to Meet

March 29, 1996

DCE Board Approves Recompetition Of Two Major Contracts

October 30, 1987

Genentech Move Nixes Hospital Discounts: Avastin, Herceptin, Rituxan Now Sold Under Tighter Control by Drug Maker

October 3, 2014